GAGNON ADVISORS LLC
Q1 2025 Form 13-F
NEW YORK, NEW YORK
CIK 0001599466
· CRD 161697
· SEC-registered investment adviser
$141.8M Reported Value Total
GAGNON ADVISORS reports 3 total accounts under management (AUM). There are 3 discretionary accounts valued at $181,145,386, and 0 non-discretionary accounts.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered
Discretionary Manager
Private funds (Form ADV)
4 funds
· $307.0M gross asset value
Hedge Fund: $307.0M
Source: Form ADV filed 2026-08-12
Reported value
$141.8M
Quarter over quarter
-12.3%
Holdings
28
Top-10 concentration
56.6%
Key People
Form ADV owners & control persons
Neil Joseph Gagnon
CHIEF EXECUTIVE OFFICER
Maureen Oneill Drew
MEMBER
Brian Joseph Gagnon
MEMBER
Filing Navigation
13F Metrics
Loading 13F Metrics
Q1 2025 13F record
Q1 2025 13F filing summary
| Period of report | March 31, 2025 |
|---|---|
| Filed | May 12, 2025 |
| Form | 13F-HR |
| Reported value | $141.8M |
| Positions | 28 |
| Change in reported value | -9.2% |
| New positions | 2 |
| Exited positions | 0 |
| Position turnover | 7.1% |
| Top-10 concentration | 56.6% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q3 2026 13F
Filed Nov 5, 2026
|
24 | $182.1M |
|
Q2 2026 13F
Filed Aug 5, 2026
|
22 | $151.1M |
|
Q1 2026 13F
Filed Apr 22, 2026
|
22 | $135.9M |
|
Q4 2025 13F
Filed Feb 13, 2026
|
23 | $157.5M |
|
Q3 2025 13F
Filed Nov 3, 2025
|
24 | $162.0M |
|
Q2 2025 13F
Filed Jul 23, 2025
|
24 | $148.8M |
|
Q1 2025 13F
Filed May 12, 2025
|
28 | $141.8M |
|
Q4 2024 13F
Filed Jan 24, 2025
|
26 | $156.2M |
|
Q3 2024 13F
Filed Nov 12, 2024
|
27 | $154.8M |
|
Q2 2024 13F
Filed Aug 14, 2024
|
27 | $131.3M |
|
Q1 2024 13F
Filed May 13, 2024
|
27 | $115.3M |
|
Q4 2023 13F
Filed Feb 14, 2024
|
26 | $114.5M |
|
Q3 2023 13F
Filed Nov 14, 2023
|
28 | $119.5M |
|
Q2 2023 13F
Filed Aug 8, 2023
|
29 | $149.4M |
|
Q1 2023 13F
Filed Apr 10, 2023
|
28 | $149.0M |
|
Q4 2022 13F
Filed Feb 7, 2023
|
29 | $148.2M |
|
Q3 2022 13F
Filed Nov 14, 2022
|
32 | $154.4M |
|
Q2 2022 13F
Filed Aug 1, 2022
|
33 | $165.1M |
|
Q1 2022 13F
Filed May 9, 2022
|
33 | $217.1M |
|
Q4 2021 13F
Filed Feb 8, 2022
|
34 | $251.7M |
32 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q1 2025
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | EPD ENTERPRISE PRODS PARTNERS L P | $11.6M | 8.18% |
| 2 | WGS GENEDX HOLDINGS CORP | $11.3M | 7.94% |
| 3 | AL AIR LEASE CORP | $9.5M | 6.69% |
| 4 | PSIX POWER SOLUTIONS INTL INC | $8.2M | 5.77% |
| 5 | CDNA CAREDX INC | $7.3M | 5.17% |
| 6 | NVGS NAVIGATOR HLDGS LTD | $6.9M | 4.85% |
| 7 | FRSH FRESHWORKS INC | $6.6M | 4.68% |
| 8 | EQIX EQUINIX INC | $6.3M | 4.47% |
| 9 | BL BLACKLINE INC | $6.3M | 4.44% |
| 10 | BLFS BIOLIFE SOLUTIONS INC | $6.3M | 4.42% |
| 11 | VRN VEREN INC | $5.9M | 4.16% |
| 12 | AMRC AMERESCO INC | $5.7M | 4.03% |
| 13 | VERX VERTEX INC | $5.7M | 4.0% |
| 14 | PROF PROFOUND MED CORP | $5.2M | 3.68% |
| 15 | ETWO E2OPEN PARENT HOLDINGS INC | $4.7M | 3.3% |
| 16 | FIVN FIVE9 INC | $4.5M | 3.21% |
| 17 | TMCI TREACE MED CONCEPTS INC | $4.1M | 2.9% |
| 18 | EXAS EXACT SCIENCES CORP | $3.8M | 2.66% |
| 19 | PCRX PACIRA BIOSCIENCES INC | $3.3M | 2.34% |
| 20 | AOSL ALPHA & OMEGA SEMICONDUCTOR LT | $3.0M | 2.11% |
Values as reported on the Q1 2025 Form 13F. Every position is in the holdings table below.